Aptevo Therapeutics Inc. Additional Paid in Capital, Common Stock
Aptevo Therapeutics Inc. (APVO) had Additional Paid in Capital, Common Stock of $294.19 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-14
- 2026-06-30: Additional Paid in Capital, Common Stock $294.19M.
- 2026-03-31: Additional Paid in Capital, Common Stock $293.41M.
- 2025-12-31: Additional Paid in Capital, Common Stock $292.38M.
- 2025-09-30: Additional Paid in Capital, Common Stock $286.50M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $294.19M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $293.41M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $292.38M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $286.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $266.61M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $252.43M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $252.25M 10-K · filed 2026-03-26 |
| 2024-09-30 | $245.60M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $240.56M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $236.32M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $235.61M 10-K · filed 2025-02-14 |
| 2023-09-30 | $232.21M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $227.41M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $226.47M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $223.96M 10-K · filed 2024-03-05 |
| 2022-09-30 | $217.11M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $216.75M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $215.83M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $215.23M 10-K · filed 2023-03-30 |
| 2021-09-30 | $215.04M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $214.63M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $203.32M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $202.15M 10-K · filed 2022-03-24 |
| 2020-09-30 | $180.71M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $180.37M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $180.07M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $179.65M 10-K · filed 2021-03-31 |
| 2019-09-30 | $179.38M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $178.91M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $178.51M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $157.79M 10-K · filed 2020-03-25 |
| 2018-09-30 | $157.26M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $156.76M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $156.00M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $155.84M 10-K · filed 2019-03-18 |
| 2017-09-30 | $154.26M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $153.24M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $152.14M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $151.27M 10-K · filed 2018-03-13 |
| 2016-09-30 | $149.49M 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |